Pfizer begins clinical trials for Omicron-specific COVID-19 vaccine - Daily Mail

Pfizer, and its partner BioNTech, have started clinical trials for a new COVID-19 vaccine that is specifically targeted at the Omicron variant, which they say could be available as early as late Marc… [+6276 chars]